PAIGE GRIFFITH: Open Payments
NPI 1639636731 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,370 in 66 payments from 12 companies in 2025. Trend: 2023 $25,831 · 2024 $44,352 · 2025 $30,370
Speaker / faculty: $25,000Food & beverage: $2,567Consulting: $1,469Travel & lodging: $1,236Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 44 | $27,351 |
| JAZZ PHARMACEUTICALS INC. | 1 | $1,075 |
| Incyte Corporation | 3 | $545 |
| Daiichi Sankyo Inc. | 3 | $362 |
| Janssen Biotech, Inc. | 3 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $182 |
| Genmab U.S., Inc. | 2 | $155 |
| Syndax Pharmaceuticals, Inc. | 1 | $144 |
| Fennec Pharmaceuticals, Inc. | 2 | $136 |
| Exelixis Inc. | 1 | $123 |
Products named: ZIIHERA, ZYNYZ, DATROWAY, Epkinly, Nubeqa, Fyarro, RYBREVANT, Pemazyre.
Industry payments across MD — which companies pay providers there.
